The activation of mitogen-activated protein kinases (MAPKs) cascade member c-Jun N-terminal kinase (JNK) was also reported in GBM and correlated with high histological grade and the poor prognosis of GBM patients [5,6]. Here, WNK2 is linked to glioblastoma.